subject: Vision Shopsters: Pharmaceutical Mergers And Acquisitions [print this page] Pharmaceutical Mergers and Acquisitions examines strategies and processes in M&A activity. Gain insight from senior executives and business development directors on overcoming the challenges inherent to any deal. Use our benchmarks and qualitative data to clarify roles, reduce the impact of attrition, and ensure a smooth transition.
The reports primary and secondary data present a comprehensive picture of the M&A landscape over the past 12 months. They address the most relevant questions, including:
For more info, visit : http://www.visionshopsters.com/product/3322/Pharmaceutical-Mergers-and-Acquisitions.html
Are you confident in your post-merger strategy? Consult our recommendations to improve the integration process and avoid costly retention problems.
Does your potential deal stack up against others? Examine metrics for 19 individual deals, including deal size, functional involvement, and employee retention rates.
What will the playing field look like in 2010? Review the top 75 deals of 2009 to determine purchasing trends, including price/pipeline ratios, financing options and deal motivators.
Table Of Contents :
Executive Summary
Profiled Companies
Methodology and Definitions
Pharmaceutical M&A: Five Principles for Success
Deal Background
Deal Foundations and Integration Processes
Resolving Integration Challenges
Managing Cultural Integration
Retaining and Eliminating Positions
Other Concerns
Pharmaceutical Mergers and Acquisitions - 2008 to 2009
The Future of M&A
Pressures Facing Small Companies
Opportunities for Acquirers
Deal Profiles
For more information on the report, kindly visit :
